A detailed history of Aqr Capital Management LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 18,908 shares of RCKT stock, worth $210,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,908
Holding current value
$210,635
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.6 - $25.88 $332,780 - $489,339
18,908 New
18,908 $349,000
Q1 2024

May 15, 2024

BUY
$26.16 - $30.74 $53,889 - $63,324
2,060 Added 25.56%
10,118 $272,000
Q4 2023

Feb 14, 2024

BUY
$16.78 - $31.94 $135,213 - $257,372
8,058 New
8,058 $241,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $843M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.